3D tumor spheroid models for in vitro therapeutic screening: A systematic approach to enhance the biological relevance of data obtained

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zanoni, Michele ^a   Piccinini, Filippo ^b   Arienti, Chiara ^a   Zamagni, Alice ^a   Santi, Spartaco ^c,d   Polico, Rolando ^a   Bevilacqua, Alessandro ^b   Tesei, Anna ^a  

^a DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c CNR   (Italy)

^d RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; CONTROLLED STUDY; CYTOTOXICITY TEST; DISEASE MODEL; HUMAN; IN VITRO STUDY; MODEL; SCREENING; TUMOR SPHEROID; BIOLOGICAL MODEL; CELL SHAPE; CELL SURVIVAL; DRUG SCREENING; FIBROBLAST; MULTICELLULAR SPHEROID; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING; TUMOR CELL CULTURE;

CELL SHAPE; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; FIBROBLASTS; HUMANS; IMAGING, THREE-DIMENSIONAL; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84954185859     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep19103     Document Type: Article

References (42)

1. Fricker, J. Time for reform in the drug-development process. Lancet Oncol. 9, 1125-1126 (2008).
2. Ocana, A., Pandiella, A., Siu, L. L. & Tannock, I. F. Preclinical development of molecular-targeted agents for cancer. Nat. Rev. Clin. Oncol. 8, 200-209 (2010).
3. Sams-Dodd, F. Target-based drug discovery: is something wrong? Drug Discov. Today 10, 139-147 (2005).
4. Edwards, A. M. et al. Preclinical target validation using patient-derived cells. Nat. Rev. Drug Discov. 14, 149-150 (2015).
5. Lee, G. Y., Kenny, P. A., Lee, E. H. & Bissell, M. J. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Methods 4, 359-365 (2007).
6. Thoma, C. R., Zimmermann, M., Agarkova, I., Kelm, J. M. & Krek, W. 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv. Drug Deliv. Rev. 69-70, 29-41 (2014).
7. Kimlin, L. C., Casagrande, G. & Virador, V. M. In vitro three-dimensional (3D) models in cancer research: an update. Mol. Carcinog. 52, 167-182 (2013).
8. Baker, B. M. & Chen, C. S. Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J. Cell. Sci. 125, 3015-3024 (2012).
9. Wartenberg, M. et al. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB J. 17, 503-505 (2003).
10. Minchinton, A. I. & Tannock, I. F. Drug penetration in solid tumours. Nat. Rev. Cancer. 6, 583-592 (2006).
11. Weiswald, L. B., Bellet, D. & Dangles-Marie, V. Spherical cancer models in tumor biology. Neoplasia 17, 1-15 (2015).
12. Yamada, K. M. & Cukierman, E. Modeling tissue morphogenesis and cancer in 3D. Cell 130, 601-610 (2007).
13. Friedrich, J., Seidel, C., Ebner, R. & Kunz-Schughart, L. A. Spheroid-based drug screen: considerations and practical approach. Nat. Protoc. 4, 309-324 (2009).
14. Jaganathan, H. et al. Three-dimensional in vitro co-culture model of breast tumor using magnetic levitation. Sci. Rep. 4, 6468 (2014).
15. Cunha, C., Panseri, S., Villa, O., Silva, D. & Gelain, F. 3D culture of adult mouse neural stem cells within functionalized self-assembling peptide scaffolds. Int. J. Nanomedicine 6, 943-955 (2011).
16. Tesei, A. et al. In vitro irradiation system for radiobiological experiments. Radiat. Oncol. 8, 257-717X-8-257 (2013).
17. Vinci, M. et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 10, 29-7007-10-29 (2012).
18. De Sousa E Melo, F., Vermeulen, L., Fessler, E. & Medema, J. P. Cancer heterogeneity-a multifaceted view. EMBO Rep. 14, 686-695 (2013).
19. Mueller-Klieser, W. Multicellular spheroids. A review on cellular aggregates in cancer research. J. Cancer Res. Clin. Oncol. 113, 101-122 (1987).
20. Mueller-Klieser, W. Three-dimensional cell cultures: from molecular mechanisms to clinical applications. Am. J. Physiol. 273, C1109-23 (1997).
21. Mueller-Klieser, W. Tumor biology and experimental therapeutics. Crit. Rev. Oncol. Hematol. 36, 123-139 (2000).
22. Hirschhaeuser, F. et al. Multicellular tumor spheroids: an underestimated tool is catching up again. J. Biotechnol. 148, 3-15 (2010).
23. Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D. & Takayama, S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J. Control. Release 164, 192-204 (2012).
24. Frankel, A., Buckman, R. & Kerbel, R. S. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Cancer Res. 57, 2388-2393 (1997).
25. Dubessy, C., Merlin, J. M., Marchal, C. & Guillemin, F. Spheroids in radiobiology and photodynamic therapy. Crit. Rev. Oncol. Hematol. 36, 179-192 (2000).
26. Kim, T. H., Mount, C. W., Gombotz, W. R. & Pun, S. H. The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles. Biomaterials 31, 7386-7397 (2010).
27. Kepp, O., Galluzzi, L., Lipinski, M., Yuan, J. & Kroemer, G. Cell death assays for drug discovery. Nat. Rev. Drug Discov. 10, 221-237 (2011).
28. Celli, J. P. et al. An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models. Sci. Rep. 4, 3751 (2014).
29. Piccinini, F. AnaSP: a software suite for automatic image analysis of multicellular spheroids. Comput. Methods Programs Biomed. 119, 43-52 (2015).
30. Piccinini, F., Tesei, A., Arienti, C. & Bevilacqua, A. Cancer multicellular spheroids: volume assessment from a single 2D projection. Comput. Methods Programs Biomed. 118, 95-106 (2015).
31. Kelm, J. M., Timmins, N. E., Brown, C. J., Fussenegger, M. & Nielsen, L. K. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol. Bioeng. 83, 173-180 (2003).
32. Huisken, J., Swoger, J., Del Bene, F., Wittbrodt, J. & Stelzer, E. H. Optical sectioning deep inside live embryos by selective plane illumination microscopy. Science 305, 1007-1009 (2004).
33. Pignatta, S. et al. Albumin nanocapsules containing fenretinide: pre-clinical evaluation of cytotoxic activity in experimental models of human non-small cell lung cancer. Nanomedicine 11, 263-273 (2015).
34. Grimm, D. et al. Growing tissues in real and simulated microgravity: new methods for tissue engineering. Tissue Eng. Part B. Rev. 20, 555-566 (2014).
35. Ingram, M. et al. Three-dimensional growth patterns of various human tumor cell lines in simulated microgravity of a NASA bioreactor. In Vitro Cell. Dev. Biol. Anim. 33, 459-466 (1997).
36. Dufau, I. et al. Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer. BMC Cancer 12, 15-2407-12-15 (2012).
37. Sorensen, A. G. et al. Comparison of diameter and perimeter methods for tumor volume calculation. J. Clin. Oncol. 19, 551-557 (2001).
38. Waschow, M., Letzsch, S., Boettcher, K. & Kelm, J. High-content analysis of biomarker intensity and distribution in 3D microtissues. Nat. Methods 9, iii-v (2012).
39. Hirschhaeuser, F., Walenta, S. & Mueller-Klieser, W. Efficacy of catumaxomab in tumor spheroid killing is mediated by its trifunctional mode of action. Cancer Immunol. Immunother. 59, 1675-1684 (2010).
40. Johnstone, B., Hering, T. M., Caplan, A. I., Goldberg, V. M. & Yoo, J. U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 238, 265-272 (1998).
41. Haisler, W. L. et al. Three-dimensional cell culturing by magnetic levitation. Nat. Protoc. 8, 1940-1949 (2013).
42. Piccinini, F., Tesei, A., Paganelli, G., Zoli, W. & Bevilacqua, A. Improving reliability of live/dead cell counting through automated image mosaicing. Comput. Methods Programs Biomed. 117, 448-463 (2014).